Deutsche Bank
KRTX

Deutsche Bank’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Deutsche Bank’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-58,632
Closed -$18.6M – 3699
2023
Q4 		$18.6M Buy
58,632
+7,048
+14% +$1.37M 0.01% 816
2023
Q3 		$8.72M Buy
51,584
+7,282
+16% +$1.37M 0.01% 892
2023
Q2 		$9.61M Sell
44,302
-27,884
-39% -$5.97M 0.01% 993
2023
Q1 		$13.1M Sell
72,186
-833
-1% -$159K 0.01% 880
2022
Q4 		$14.3M Buy
73,019
+2,688
+4% +$576K 0.01% 847
2022
Q3 		$15.8M Buy
70,331
+20,126
+40% +$4.07M 0.01% 826
2022
Q2 		$6.35M Buy
50,205
+5,487
+12% +$631K ﹤0.01% 1183
2022
Q1 		$5.67M Sell
44,718
-1,325
-3% -$149K ﹤0.01% 1361
2021
Q4 		$6.03M Sell
46,043
-1,025
-2% -$132K ﹤0.01% 1336
2021
Q3 		$5.76M Sell
47,068
-4,352
-8% -$502K ﹤0.01% 1423
2021
Q2 		$5.86M Buy
51,420
+3,316
+7% +$388K ﹤0.01% 1434
2021
Q1 		$5.78M Sell
48,104
-31,375
-39% -$3.55M ﹤0.01% 1465
2020
Q4 		$8.07M Buy
79,479
+4,417
+6% +$409K ﹤0.01% 1135
2020
Q3 		$5.8M Buy
75,062
+754
+1% +$64.3K ﹤0.01% 1201
2020
Q2 		$8.28M Sell
74,308
-2,890
-4% -$251K 0.01% 1058
2020
Q1 		$5.56M Sell
77,198
-4,482
-5% -$383K 0.01% 1197
2019
Q4 		$6.15M Buy
81,680
+30,418
+59% +$1.33M ﹤0.01% 1331
2019
Q3 		$834K Buy
+51,262
New +$996K ﹤0.01% 2405

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Deutsche Bank's KRTX Position: Q1 2024 in Review

Deutsche Bank sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 58,632 shares — an estimated $18.6M sold.

Deutsche Bank first reported a position in KRTX in Q3 2019 and held it in 18 quarters. The position peaked at $18.6M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Deutsche Bank reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Deutsche Bank sold 58,632 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $18.6M.
  • Deutsche Bank first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 18 quarters.
  • Deutsche Bank's Karuna Therapeutics, Inc. Common Stock position peaked at $18.6M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.